MANE Veradermics, Inc.

$112.71

Veradermics, Inc. (MANE) is expected to report earnings on November 10, 2026, before the market open. The consensus earnings estimate is a loss of $0.59 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.8% since its last earnings release on August 11, 2026.

Veradermics Reported In-line with Estimates
Tuesday, August 11, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 10
Tuesday · 7:30 AM ET
Earnings Whisper
-
vs ($0.59)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $110.04

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow